Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology

Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment... see more

Add To Watchlist

Recent & Breaking News (NDAQ:IMNN)

Celsion Corporation Announces Strategic Loan Facility

PR Newswire November 26, 2013

Celsion Corporation Reports Third Quarter 2013 Financial Results and Provides Business Update

PR Newswire November 12, 2013

Celsion Corporation to Hold Third Quarter 2013 Financial Results Conference Call on Tuesday, November 12, 2013

PR Newswire November 6, 2013

TrendingWallStreet.com Issues Research Reports on DAN, AEGY, GLER, and CLSN

Accesswire October 30, 2013

Celsion Corporation Announces Stock Consolidation

PR Newswire October 28, 2013

SIRI, ZIOP, PRKR and CLSN added to NASDAQ Active Stock Watch List at EPR

Accesswire October 24, 2013

Celsion Corporation Provides Clinical Update on ThermoDox® HEAT Study Findings

PR Newswire October 24, 2013

Celsion Corporation's ThermoDox® HEAT Study Findings Reviewed at the International Liver Cancer Association (ILCA) 2013 Annual Conference in Washington, D.C. on September 14, 2013

PR Newswire September 16, 2013

Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference

PR Newswire September 9, 2013

Celsion to Present at the Rodman & Renshaw Global Investment Conference

PR Newswire September 6, 2013

Celsion Announces Official ThermoDox® HEAT Study Results to be presented at the International Liver Cancer Association (ILCA) 2013 Annual Conference in Washington, D.C. on September 14, 2013

PR Newswire August 21, 2013

Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update

PR Newswire August 8, 2013

Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013

PR Newswire August 1, 2013

Celsion Corporation and Zhejiang Hisun Pharmaceutical Company Sign Memorandum of Understanding for Future Development of ThermoDox® and Other Liposomal Formulations

PR Newswire July 19, 2013

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celsion Corp.

PR Newswire July 15, 2013

Celsion Announces ThermoDox® HEAT Study Findings To Be Presented at the International Liver Cancer Association (ILCA) 2013 Annual Conference in Washington, DC on September 14, 2013

PR Newswire July 11, 2013

Celsion Announces Jeffrey W. Church Reappointed to CFO

PR Newswire July 2, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on CLSN, MNKD, NKTR and VPHM

Accesswire June 24, 2013

Celsion's ThermoDox® HEAT Study Findings Reviewed at the 2013 European Conference on Interventional Oncology (ECIO) in Budapest, Hungary on June 19 and 20, 2013

PR Newswire June 20, 2013

Start Making Profits Now With CLNT, AFFY, TSLA and CLSN

Marketwired June 19, 2013